These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2069843)

  • 21. Increased catabolic activity in adipose tissue of patients with chronic heart failure.
    Szabó T; Postrach E; Mähler A; Kung T; Turhan G; von Haehling S; Anker SD; Boschmann M; Doehner W
    Eur J Heart Fail; 2013 Oct; 15(10):1131-7. PubMed ID: 23696611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum adipokine zinc α2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers.
    Tedeschi S; Pilotti E; Parenti E; Vicini V; Coghi P; Montanari A; Regolisti G; Fiaccadori E; Cabassi A
    Metabolism; 2012 Jan; 61(1):37-42. PubMed ID: 21696792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new experimental model of human cachexia.
    Strain AJ; Easty GC; Neville AM
    Invest Cell Pathol; 1979; 2(2):87-96. PubMed ID: 511610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New cachexic factors.
    Tisdale MJ
    Curr Opin Clin Nutr Metab Care; 1998 May; 1(3):253-6. PubMed ID: 10565357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia.
    Bing C; Bao Y; Jenkins J; Sanders P; Manieri M; Cinti S; Tisdale MJ; Trayhurn P
    Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2500-5. PubMed ID: 14983038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice.
    Beck SA; Tisdale MJ
    Cancer Res; 1989 Jul; 49(14):3800-4. PubMed ID: 2736521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of lipid-depleting factor in a colon-26-inoculated cancer cachexia model.
    Inadera H; Nagai S; Dong HY; Matsushima K
    Int J Cancer; 2002 Sep; 101(1):37-45. PubMed ID: 12209586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-host interactions.
    Tisdale MJ
    J Cell Biochem; 2004 Nov; 93(5):871-7. PubMed ID: 15449322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients.
    Wolf I; Sadetzki S; Kanety H; Kundel Y; Pariente C; Epstein N; Oberman B; Catane R; Kaufman B; Shimon I
    Cancer; 2006 Feb; 106(4):966-73. PubMed ID: 16411208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of weight loss by omega-3 fatty acids in an experimental cachexia model.
    Tisdale MJ; Dhesi JK
    Cancer Res; 1990 Aug; 50(16):5022-6. PubMed ID: 2379167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight loss in tumour-bearing mice is not associated with changes in resistin gene expression in white adipose tissue.
    Gómez-Ambrosi J; Zabalegui N; Bing C; Tisdale MJ; Trayhurn P; Williams G
    Horm Metab Res; 2002; 34(11-12):674-7. PubMed ID: 12660881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia.
    Gelin J; Moldawer LL; Lönnroth C; Sherry B; Chizzonite R; Lundholm K
    Cancer Res; 1991 Jan; 51(1):415-21. PubMed ID: 1703040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of cancer cachexia.
    Tisdale MJ
    J Support Oncol; 2003; 1(3):159-68. PubMed ID: 15334872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host.
    Beck SA; Tisdale MJ
    Cancer Res; 1987 Nov; 47(22):5919-23. PubMed ID: 3311359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF).
    Islam-Ali B; Khan S; Price SA; Tisdale MJ
    Br J Cancer; 2001 Sep; 85(5):758-63. PubMed ID: 11531264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models.
    Fujimoto-Ouchi K; Onuma E; Shirane M; Mori K; Tanaka Y
    Cancer Chemother Pharmacol; 2007 May; 59(6):807-15. PubMed ID: 17009035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azaftig, a urinary proteoglycan from a cachectic cancer patient, causes profound weight loss in mice.
    Figueroa J; Vijayagopal P; Debata C; Prasad A; Prasad C
    Life Sci; 1999; 64(15):1339-47. PubMed ID: 10227590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zinc-alpha2-glycoprotein in cachexia and obesity.
    Tisdale MJ
    Curr Opin Support Palliat Care; 2009 Dec; 3(4):288-93. PubMed ID: 19823091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zinc-α2-glycoprotein as a marker of fat catabolism in humans.
    Cabassi A; Tedeschi S
    Curr Opin Clin Nutr Metab Care; 2013 May; 16(3):267-71. PubMed ID: 23448999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of increased lipolysis in cancer cachexia.
    Agustsson T; Rydén M; Hoffstedt J; van Harmelen V; Dicker A; Laurencikiene J; Isaksson B; Permert J; Arner P
    Cancer Res; 2007 Jun; 67(11):5531-7. PubMed ID: 17545636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.